Jocelyn P C
Biochem J. 1978 Dec 15;176(3):649-64. doi: 10.1042/bj1760649.
Diamide is reduced by mitochondria utilizing endogenous substrates with Vmax. 20nmol/min per mg of protein and Km 75micrometer. The reaction is inhibited by: (a) thiol-blocking reagents (N-ethylmaleimide, p-hydroxymercuribenzoate, mersalyl and 2,6-dichlorophenol-indophenol);(b) respiratory inhibitors (arsenicals, malonate and antimycin, but not cyanide or oligomycin; inhibition by antimycin is reversed by ATP); (c) uncouplers (carbonyl cyanide p-trifluoromethoxyphenylhydrazone, 2,4-dinitrophenol and valinomycin with K+; inhibition by the first of these uncouplers is not reversed by cyanide); (d) reagents affecting energy conservation (Ca2+, increasing pH, phosphate; phosphate inhibition is augmented by catalytic ADP or ATP and augmentation is abolished by respiratory inhibitors). Concentrations of mitochondrial glutathione are high when diamide reduction is uninhibited, but low after adding one of the above inhibitors such that the reduction rate is roughly proportional to the glutathione concentration. Endogenous ATP concentrations are lower in the presence of diamide than without, but the difference is abolished by respiratory inhibitors. With oligomycin added, however, ATP concentrations are higher in the presence of diamide and this positive increment is decreased by antimycin, N-ethylmaleimide and malonate. In the presence of diamide and an uncoupler, the mitochondrial glutathione content does not fall if various reducible substrates are present, although the inhibition of diamide reduction is not relieved. Some of these substrates prevent the fall in reduced glutathione concentration found with diamide and phosphate. They also relieve the inhibition of diamide reduction and the relief is sensitive to butylmalonate. The inhibition of diamide reduction by N-ethylmaleimide, mersalyl or p-hydroxymercuribenzoate is not relieved by reducible substrates, but the latter mitigate the fall in the concentration of glutathione. Inhibitors of carriers of tricarboxylic acid-cycle intermediates also inhibit reduction of diamide. The reduced glutathione concentration remains high when they are added singly, but falls when two of them are combined. It is proposed that diamide may enter the matrix as a protonated adduct formed with the thiol groups of mitochondrial carriers and then be reduced in the matrix by glutathione, which is regenerated via NADH, energy-dependent transhydrogenase and NADP+-specific glutathione reductase. Some of the high-energy equivalents required for the transhydrogeneration may be generated by the substrate phosphorylation step of the tricarboxylic acid cycle.
线粒体利用内源性底物可使二酰胺还原,其最大反应速度(Vmax)为每毫克蛋白质20纳摩尔/分钟,米氏常数(Km)为75微摩尔。该反应受到以下物质的抑制:(a)巯基阻断试剂(N - 乙基马来酰亚胺、对羟基汞苯甲酸、汞撒利和2,6 - 二氯酚靛酚);(b)呼吸抑制剂(砷制剂、丙二酸和抗霉素,但不包括氰化物或寡霉素;抗霉素引起的抑制可被ATP逆转);(c)解偶联剂(羰基氰对三氟甲氧基苯腙、2,4 - 二硝基苯酚和钾离子载体缬氨霉素;这些解偶联剂中的第一种引起的抑制不能被氰化物逆转);(d)影响能量守恒的试剂(钙离子、升高的pH值、磷酸盐;磷酸盐抑制作用会被催化性ADP或ATP增强,而这种增强会被呼吸抑制剂消除)。当二酰胺还原未受抑制时,线粒体谷胱甘肽浓度较高,但添加上述抑制剂之一后浓度降低,使得还原速率大致与谷胱甘肽浓度成正比。在有二酰胺存在的情况下,内源性ATP浓度比没有时低,但这种差异会被呼吸抑制剂消除。然而,添加寡霉素后,在有二酰胺存在时ATP浓度较高,而抗霉素、N - 乙基马来酰亚胺和丙二酸会降低这种正向增加。在有二酰胺和解偶联剂存在的情况下,如果存在各种可还原底物,线粒体谷胱甘肽含量不会下降,尽管二酰胺还原的抑制并未解除。其中一些底物可防止因二酰胺和磷酸盐导致的还原型谷胱甘肽浓度下降。它们还可缓解二酰胺还原的抑制作用,且这种缓解对丁基丙二酸敏感。可还原底物不能解除N - 乙基马来酰亚胺、汞撒利或对羟基汞苯甲酸对二酰胺还原的抑制,但后者可减轻谷胱甘肽浓度的下降。三羧酸循环中间产物载体的抑制剂也会抑制二酰胺的还原。单独添加时,还原型谷胱甘肽浓度保持较高,但两种抑制剂联合添加时浓度会下降。有人提出,二酰胺可能作为与线粒体载体的巯基形成的质子化加合物进入线粒体基质,然后在基质中被谷胱甘肽还原,谷胱甘肽通过NADH、能量依赖的转氢酶和NADP⁺特异性谷胱甘肽还原酶再生。转氢过程所需的一些高能等价物可能由三羧酸循环的底物磷酸化步骤产生。